KEGG   DRUG: LabetuzumabHelp
Entry
D08936                      Drug                                   

Name
Labetuzumab (INN/USAN)
Remark
Chemical group: 
Efficacy
Antineoplastic, Anti-CEA antibody
Comment
Monoclonal antibody
Treatment of colorectal cancer (humanized monoclonal antibody hMN-14 targeting CEA-positive cancer)
Brite
Target-based classification of drugs [BR:br08310]
 Monoclonal antibody
  CD66 (CEACAM)
   Labetuzumab
    D08936  Labetuzumab (INN/USAN)
BRITE hierarchy
Other DBs
CAS: 
219649-07-7
PubChem: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system